Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1948 2
1950 2
1951 2
1954 7
1955 2
1956 5
1957 1
1958 4
1959 1
1960 1
1961 1
1962 2
1963 3
1964 4
1965 5
1968 2
1969 1
1971 1
1973 1
1975 1
1976 3
1977 4
1978 16
1979 14
1980 15
1981 17
1982 23
1983 18
1984 25
1985 17
1986 21
1987 24
1988 24
1989 26
1990 26
1991 24
1992 36
1993 33
1994 35
1995 28
1996 28
1997 35
1998 39
1999 35
2000 38
2001 32
2002 33
2003 43
2004 51
2005 31
2006 42
2007 57
2008 45
2009 49
2010 57
2011 60
2012 63
2013 57
2014 65
2015 71
2016 66
2017 67
2018 78
2019 81
2020 105
2021 111
2022 121
2023 119
2024 100
2025 41

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,094 results

Results by year

Filters applied: . Clear all
Page 1
Tenosynovial giant cell tumor.
Kager M, Kager R, Fałek P, Fałek A, Szczypiór G, Niemunis-Sawicka J, Rzepecka-Wejs L, Starosławska E, Burdan F. Kager M, et al. Folia Med Cracov. 2022;62(2):93-107. doi: 10.24425/fmc.2022.141702. Folia Med Cracov. 2022. PMID: 36256897 Free article.
Tenosynovial Giant Cell Tumor (TGCT) is a group of typically benign lesions arising from the synovium of joints, bursae and tendon sheaths. ...It is predominantly caused by a mutation in the stromal cells of the synovial membrane leading to over
Tenosynovial Giant Cell Tumor (TGCT) is a group of typically benign lesions arising from the synovium of joints,
Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts.
Stacchiotti S, Dürr HR, Schaefer IM, Woertler K, Haas R, Trama A, Caraceni A, Bajpai J, Baldi GG, Bernthal N, Blay JY, Boye K, Broto JM, Chen WT, Dei Tos PA, Desai J, Emhofer S, Eriksson M, Gronchi A, Gelderblom H, Hardes J, Hartmann W, Healey J, Italiano A, Jones RL, Kawai A, Leithner A, Loong H, Mascard E, Morosi C, Otten N, Palmerini E, Patel SR, Reichardt P, Rubin B, Rutkowski P, Sangalli C, Schuster K, Seddon BM, Shkodra M, Staals EL, Tap W, van de Rijn M, van Langevelde K, Vanhoenacker FMM, Wagner A, Wiltink L, Stern S, Van de Sande VM, Bauer S. Stacchiotti S, et al. Cancer Treat Rev. 2023 Jan;112:102491. doi: 10.1016/j.ctrv.2022.102491. Epub 2022 Dec 6. Cancer Treat Rev. 2023. PMID: 36502615 Free article. Review.
Tenosynovial giant cell tumour (TGCT) is a rare, locally aggressive, mesenchymal tumor arising from the joints, bursa and tendon sheaths. ...
Tenosynovial giant cell tumour (TGCT) is a rare, locally aggressive, mesenchymal tumor arising from the joints,
Treatment updates on tenosynovial giant cell tumor.
Palmerini E, Staals EL. Palmerini E, et al. Curr Opin Oncol. 2022 Jul 1;34(4):322-327. doi: 10.1097/CCO.0000000000000853. Curr Opin Oncol. 2022. PMID: 35837703 Review.
PURPOSE OF REVIEW: Diffuse-type tenosynovial giant cell tumor (dt-TGCT) is a benign clonal neoplastic proliferation arising from the synovium. ...RECENT FINDINGS: TGCT cells overexpress colony-stimulating factor 1 (CSF1), resulting in recruitment of CS …
PURPOSE OF REVIEW: Diffuse-type tenosynovial giant cell tumor (dt-TGCT) is a benign clonal neoplastic proliferat …
Updates on the Treatment of Tenosynovial Giant Cell Tumor.
Chan AS, Katiyar V, Dy P, Singh V. Chan AS, et al. Hematol Oncol Stem Cell Ther. 2023 May 23;16(4):307-315. doi: 10.56875/2589-0646.1032. Hematol Oncol Stem Cell Ther. 2023. PMID: 37363972 Free article. Review.
Tenosynovial giant cell tumor (TGCT) is a rare inflammatory disorder affecting the joint synovium, bursae, and tendon sheaths that causes non-specific and often insidious joint discomfort. ...
Tenosynovial giant cell tumor (TGCT) is a rare inflammatory disorder affecting the joint synovium, bursae, and
Optimal Treatment for Tenosynovial Giant Cell Tumor of the Hand.
Kitagawa Y, Takai S. Kitagawa Y, et al. J Nippon Med Sch. 2020 Sep 9;87(4):184-190. doi: 10.1272/jnms.JNMS.2020_87-408. Epub 2020 Apr 30. J Nippon Med Sch. 2020. PMID: 32350187 Free article. Review.
This review examines the following aspects of tenosynovial giant cell tumors (TSGCTs): the use of multiple names, the complex relationship between tumor growth pattern and location, the high rate of postoperative recurrence, local invasiveness, use of …
This review examines the following aspects of tenosynovial giant cell tumors (TSGCTs): the use of multiple names, the c …
Management of Tenosynovial Giant Cell Tumor: A Neoplastic and Inflammatory Disease.
Healey JH, Bernthal NM, van de Sande M. Healey JH, et al. J Am Acad Orthop Surg Glob Res Rev. 2020 Nov;4(11):e20.00028. doi: 10.5435/JAAOSGlobal-D-20-00028. J Am Acad Orthop Surg Glob Res Rev. 2020. PMID: 33156160 Free PMC article.
BACKGROUND: Patients with diffuse tenosynovial giant cell tumor (TGCT) face a high risk of recurrence, progression, and disability. ...METHODS: We searched PubMed and Ovid with the terms "Giant cell tumor of tendon
BACKGROUND: Patients with diffuse tenosynovial giant cell tumor (TGCT) face a high risk of recurrence, progressi …
Prospects of Treating Tenosynovial Giant Cell Tumor through Pexidartinib: A Review.
Alsayadi YMMA, Chawla PA. Alsayadi YMMA, et al. Anticancer Agents Med Chem. 2021;21(12):1510-1519. doi: 10.2174/1871520620999201102123555. Anticancer Agents Med Chem. 2021. PMID: 33143617 Review.
BACKGROUND: Tenosynovial giant cell tumor refers to a group of rarely occurring tumors that are formed in the joints, which are characterized by pain, swelling, and limitation of movement of the joint. Surgery is the main treatment strategy, but the …
BACKGROUND: Tenosynovial giant cell tumor refers to a group of rarely occurring tumors that are formed in the jo …
Update on Tenosynovial Giant Cell Tumor, an Inflammatory Arthritis With Neoplastic Features.
Robert M, Farese H, Miossec P. Robert M, et al. Front Immunol. 2022 Feb 21;13:820046. doi: 10.3389/fimmu.2022.820046. eCollection 2022. Front Immunol. 2022. PMID: 35265077 Free PMC article.
Other explanations can come from observations of tenosynovial giant cell tumor (TGCT), first considered as an inflammatory arthritis, but with unusual neoplastic features. ...
Other explanations can come from observations of tenosynovial giant cell tumor (TGCT), first considered as an in …
Diffuse-Type Tenosynovial Giant Cell Tumor An Update of Current Management Strategies.
Naja A, Abboud A, Masrouha K, Ghert M, Saghieh S. Naja A, et al. Bull Hosp Jt Dis (2013). 2024 Sep;82(3):178-185. Bull Hosp Jt Dis (2013). 2024. PMID: 39150871 Review.
Diffuse-type giant cell tumor (Dt-GCT), formerly known as pigmented villonodular synovitis, is the more aggressive entity belonging to the spectrum of benign proliferative lesions of synovial origin that may affect the joints, bursae, and tendon sheath …
Diffuse-type giant cell tumor (Dt-GCT), formerly known as pigmented villonodular synovitis, is the more aggressive enti …
Tenosynovial giant cell tumor of cruciate ligament: A case report and review.
Tu NV, Quyen NVS, Ngoc MH, Trung HP, Nguyen BS, Trung DT. Tu NV, et al. Int J Surg Case Rep. 2022 Feb;91:106771. doi: 10.1016/j.ijscr.2022.106771. Epub 2022 Jan 15. Int J Surg Case Rep. 2022. PMID: 35091349 Free PMC article.
INTRODUCTION: Tenosynovial giant cell tumor (TSGCT) is a slow-growing soft tissue tumor that develops from the synovial tissue of tendon sheaths, joints, or bursae. In the knee, this type of tumor is uncommon. Giant cell
INTRODUCTION: Tenosynovial giant cell tumor (TSGCT) is a slow-growing soft tissue tumor that develops fro …
2,094 results